Brenda O'Shea, MD
Psychiatry · Valparaiso, INNPI 1538506522
Payments from drug & device makers
Across 191 payments — averaging $17.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$959
- Otsuka America Pharmaceutical, Inc.$431
- Corium, LLC$279
- Vanda Pharmaceuticals Inc.$275
- Lundbeck LLC$272
- Takeda Pharmaceuticals U.S.A., Inc.$182
- plus $890 from 15 others
What the payments were for
- Food & beverage$3,274100%
- Education$150%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 55 | $959 |
| Otsuka America Pharmaceutical, Inc. | 24 | $431 |
| Corium, LLC | 22 | $279 |
| Vanda Pharmaceuticals Inc. | 15 | $275 |
| Lundbeck LLC | 17 | $272 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $182 |
| Alkermes, Inc. | 6 | $177 |
| Teva Pharmaceuticals USA, Inc. | 9 | $140 |
| Supernus Pharmaceuticals, Inc. | 6 | $122 |
| E.r. Squibb & Sons, L.L.C. | 5 | $104 |
| Neurocrine Biosciences, Inc. | 5 | $85 |
| Bausch Health US, LLC | 4 | $62 |
| Sunovion Pharmaceuticals Inc. | 3 | $56 |
| Johnson & Johnson | 2 | $46 |
| Vertical Pharmaceuticals, LLC | 1 | $20 |
| Almatica Pharma LLC | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $13 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
| Adlon Therapeutics L.p. | 1 | $11 |
| Shire North American Group Inc | 1 | $11 |
| Tris Pharma Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,289 in reported general payments places this provider in the 80th percentile of 514 psychiatry providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 91 | $144,337 |
| Abilify MaintenaAripiprazole | 46 | $136,159 |
| RexultiBrexpiprazole | 27 | $52,997 |
| Invega SustennaPaliperidone Palmitate | 13 | $46,564 |
| Aripiprazole | 174 | $25,653 |
| TrintellixVortioxetine Hydrobromide | 36 | $20,452 |
| Lurasidone Hcl | 50 | $8,190 |
| Quetiapine Fumarate | 226 | $6,434 |
| Paliperidone ErPaliperidone | 24 | $6,090 |
| Bupropion XlBupropion Hcl | 194 | $4,648 |
| Ziprasidone Hcl | 34 | $4,571 |
| Chlorpromazine Hcl | 13 | $4,058 |
| Eszopiclone | 46 | $4,021 |
| Buspirone Hcl | 203 | $3,607 |
| Divalproex Sodium ErDivalproex Sodium | 41 | $3,128 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti | $431 | $189,15673 claims |
| AbbVieVraylar | $959 | $144,33791 claims |
| Johnson & JohnsonInvega Sustenna | $46 | $46,56413 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $182 | $20,45236 claims |
| Almatica Pharma LLCSertraline Hcl | $17 | $1,10199 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 514 psychiatry providers in Indiana.
Other psychiatry in Valparaiso
- Samir GuptaValparaiso$14K
- Linda MunsonValparaiso$7K
- Steven PaulCarmel$2.9M
- Jay FawverAngola$1.4M
- Suhayl NasrMichigan City$788K
- Christopher BojrabCarmel$714K
- Joseph FanelliMunster$443K
- Anantha ShekharIndianapolis$433K
- Eric JaggersJeffersonville$260K
- Larry LambertsonFort Wayne$208K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.